Therapeutic Asset Ratings

705 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Cyclophosphamide CBL-Related Disorder	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Cyclophosphamide Chromosomal Disorder	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Cyclophosphamide Hereditary Persistence Of Fetal Hemoglobin	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Cyclophosphamide Transplant Rejection	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Cyclophosphamide B-Lymphoblastic Leukemia/Lymphoma With IAMP21	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Cyclophosphamide Monosomy 7 Myelodysplasia And Leukemia Syndrome 1	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Cyclophosphamide Neurofibromatosis Type 1	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Cyclophosphamide NF1 Mutation	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Cyclophosphamide N-RAS Gene Amplification	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Cyclophosphamide PTPN11 Gene Mutation	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Cyclophosphamide Somatic Mutation	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Cyclophosphamide T Cell Receptor Alpha/Beta Depletion	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Cytosin-Arabinosid Autologous Stem Cell Transplant	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Dfn-15 Acyl-CoA Oxidase Deficiency	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Dfn-15 Adrenoleukodystrophy With Cerebral Involvement	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Dfn-15 Alpha-Mannosidosis	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Dfn-15 Alpha-methylacyl-CoA Racmase Deficiency	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Dfn-15 Aspartylglucosaminuria	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Dfn-15 D-Bifunctional Enzyme Deficiency	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Dfn-15 Fucosidosis	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Dfn-15 Globoid Cell Leukodystrophy	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Dfn-15 Glycoprotein Metabolic Disorders	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Dfn-15 Hereditary Leukoencephalopathy With Axonal Spheroids (HDLS; CSF1R Mutation)	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Dfn-15 Hunter Syndrome	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Dfn-15 Hurler Syndrome	Masonic Cancer Center, University of Minnesota	P2	CCC (53)

Showing 276 to 300 of 705 assets

PreviousPage 12 of 29Next